Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Thoracic 1

Conditions

Vomiting 4Nausea 4Breast Neoplasms 3Neoplasms 2Lung Neoplasms 1

Interventions

Dexamethasone 38Aprepitant 31Ondansetron 27Palonosetron 25Granisetron 16Calcium Dobesilate 15Olanzapine 12Therapeutics 8dexamethasone acetate 7Cyclophosphamide 7fosaprepitant 6casopitant 6Doxorubicin 6Radiotherapy 5netupitant 4dolasetron 4dexamethasone 21-phosphate 4Vincristine 4Tropisetron 4Metoclopramide 4Acupressure 4Yoga 3Psychiatric Rehabilitation 3Prochlorperazine 3Lorazepam 3Electroacupuncture 3Dronabinol 3Cisplatin 3Analgesia 3peppermint oil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Nausea × netupitant × Clear all
NCT03040726 2023-10-17

Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2/3 Completed
53 enrolled 15 charts

Nausea, Neoplasms, Vomiting

NCT04669132 2022-02-23

OLNEPA

Instituto Brasileiro de Controle do Cancer

Phase 2 Completed
50 enrolled
Breast

Breast Neoplasms, Nausea

NCT04201769 2020-04-03

LUNG-NEPA

Consorzio Oncotech

Phase 3 Unknown
261 enrolled
Thoracic

Lung Neoplasms, Nausea, Vomiting

NCT03862144 2019-03-05

GIM15-NEPA

Consorzio Oncotech

Phase 2 Completed
150 enrolled
Breast

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡